nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—Cytochrome P450 3A4 Inhibitors—Ritonavir—acquired immunodeficiency syndrome	0.257	0.5	CiPCiCtD
Amprenavir—Cytochrome P450 3A4 Inhibitors—Efavirenz—acquired immunodeficiency syndrome	0.257	0.5	CiPCiCtD
Amprenavir—ABCC1—Indinavir—acquired immunodeficiency syndrome	0.0181	0.051	CbGbCtD
Amprenavir—ABCC1—Ritonavir—acquired immunodeficiency syndrome	0.0159	0.0447	CbGbCtD
Amprenavir—ABCC1—Saquinavir—acquired immunodeficiency syndrome	0.0159	0.0447	CbGbCtD
Amprenavir—ABCC1—Lamivudine—acquired immunodeficiency syndrome	0.0118	0.0332	CbGbCtD
Amprenavir—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0116	0.0327	CbGbCtD
Amprenavir—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0109	0.0307	CbGbCtD
Amprenavir—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0109	0.0307	CbGbCtD
Amprenavir—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.00859	0.0242	CbGbCtD
Amprenavir—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.00827	0.0233	CbGbCtD
Amprenavir—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.00777	0.0219	CbGbCtD
Amprenavir—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.00748	0.0211	CbGbCtD
Amprenavir—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.00747	0.021	CbGbCtD
Amprenavir—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.00737	0.0208	CbGbCtD
Amprenavir—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.00693	0.0195	CbGbCtD
Amprenavir—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.00671	0.0189	CbGbCtD
Amprenavir—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.00651	0.0183	CbGbCtD
Amprenavir—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.00627	0.0177	CbGbCtD
Amprenavir—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.00613	0.0173	CbGbCtD
Amprenavir—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.00589	0.0166	CbGbCtD
Amprenavir—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.00589	0.0166	CbGbCtD
Amprenavir—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.00576	0.0162	CbGbCtD
Amprenavir—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.00576	0.0162	CbGbCtD
Amprenavir—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.00566	0.016	CbGbCtD
Amprenavir—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.00566	0.016	CbGbCtD
Amprenavir—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0056	0.0158	CbGbCtD
Amprenavir—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.00559	0.0158	CbGbCtD
Amprenavir—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.00543	0.0153	CbGbCtD
Amprenavir—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.00541	0.0152	CbGbCtD
Amprenavir—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.00527	0.0148	CbGbCtD
Amprenavir—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.00527	0.0148	CbGbCtD
Amprenavir—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.00525	0.0148	CbGbCtD
Amprenavir—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.00521	0.0147	CbGbCtD
Amprenavir—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00476	0.0134	CbGbCtD
Amprenavir—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.00475	0.0134	CbGbCtD
Amprenavir—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.00475	0.0134	CbGbCtD
Amprenavir—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00455	0.0128	CbGbCtD
Amprenavir—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0045	0.0127	CbGbCtD
Amprenavir—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00437	0.0123	CbGbCtD
Amprenavir—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00437	0.0123	CbGbCtD
Amprenavir—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00424	0.0119	CbGbCtD
Amprenavir—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00411	0.0116	CbGbCtD
Amprenavir—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00399	0.0112	CbGbCtD
Amprenavir—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00395	0.0111	CbGbCtD
Amprenavir—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00395	0.0111	CbGbCtD
Amprenavir—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00383	0.0108	CbGbCtD
Amprenavir—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00383	0.0108	CbGbCtD
Amprenavir—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00379	0.0107	CbGbCtD
Amprenavir—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00367	0.0104	CbGbCtD
Amprenavir—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00361	0.0102	CbGbCtD
Amprenavir—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00361	0.0102	CbGbCtD
Amprenavir—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00356	0.01	CbGbCtD
Amprenavir—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00335	0.00944	CbGbCtD
Amprenavir—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00335	0.00944	CbGbCtD
Amprenavir—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00303	0.00854	CbGbCtD
Amprenavir—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00284	0.00801	CbGbCtD
Amprenavir—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00262	0.00737	CbGbCtD
Amprenavir—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00254	0.00715	CbGbCtD
Amprenavir—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0023	0.00647	CbGbCtD
Amprenavir—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0023	0.00647	CbGbCtD
Amprenavir—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0022	0.0062	CbGbCtD
Amprenavir—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000461	0.0597	CbGeAlD
Amprenavir—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000402	0.0521	CbGeAlD
Amprenavir—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000363	0.047	CbGeAlD
Amprenavir—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.000361	0.0467	CbGeAlD
Amprenavir—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000358	0.0463	CbGeAlD
Amprenavir—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000273	0.0353	CbGeAlD
Amprenavir—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000268	0.0347	CbGeAlD
Amprenavir—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000193	0.025	CbGeAlD
Amprenavir—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000177	0.023	CbGeAlD
Amprenavir—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.000174	0.0225	CbGeAlD
Amprenavir—ABCC1—blood—acquired immunodeficiency syndrome	0.000173	0.0224	CbGeAlD
Amprenavir—CYP2C19—blood—acquired immunodeficiency syndrome	0.000169	0.0219	CbGeAlD
Amprenavir—ABCC1—vagina—acquired immunodeficiency syndrome	0.000161	0.0208	CbGeAlD
Amprenavir—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000157	0.0203	CbGeAlD
Amprenavir—ABCC1—lung—acquired immunodeficiency syndrome	0.000152	0.0197	CbGeAlD
Amprenavir—CYP2C8—blood—acquired immunodeficiency syndrome	0.000147	0.0191	CbGeAlD
Amprenavir—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000141	0.0182	CbGeAlD
Amprenavir—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.00014	0.0181	CbGeAlD
Amprenavir—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000139	0.018	CbGeAlD
Amprenavir—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000137	0.0178	CbGeAlD
Amprenavir—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000137	0.0177	CbGeAlD
Amprenavir—CYP3A5—blood—acquired immunodeficiency syndrome	0.000133	0.0172	CbGeAlD
Amprenavir—CYP2B6—blood—acquired immunodeficiency syndrome	0.000132	0.0171	CbGeAlD
Amprenavir—CYP2C9—blood—acquired immunodeficiency syndrome	0.000131	0.017	CbGeAlD
Amprenavir—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000123	0.016	CbGeAlD
Amprenavir—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000123	0.0159	CbGeAlD
Amprenavir—CYP3A5—lung—acquired immunodeficiency syndrome	0.000117	0.0151	CbGeAlD
Amprenavir—CYP2B6—lung—acquired immunodeficiency syndrome	0.000116	0.015	CbGeAlD
Amprenavir—ABCC1—brain—acquired immunodeficiency syndrome	0.000107	0.0139	CbGeAlD
Amprenavir—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000107	0.0139	CbGeAlD
Amprenavir—ABCB1—retina—acquired immunodeficiency syndrome	0.000106	0.0137	CbGeAlD
Amprenavir—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000105	0.0136	CbGeAlD
Amprenavir—ABCC1—lymph node—acquired immunodeficiency syndrome	0.000104	0.0134	CbGeAlD
Amprenavir—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000103	0.0134	CbGeAlD
Amprenavir—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000103	0.0134	CbGeAlD
Amprenavir—CYP3A4—blood—acquired immunodeficiency syndrome	9.99e-05	0.0129	CbGeAlD
Amprenavir—CYP2D6—blood—acquired immunodeficiency syndrome	9.83e-05	0.0127	CbGeAlD
Amprenavir—CYP2C8—brain—acquired immunodeficiency syndrome	9.15e-05	0.0118	CbGeAlD
Amprenavir—CYP2B6—brain—acquired immunodeficiency syndrome	8.21e-05	0.0106	CbGeAlD
Amprenavir—CYP3A4—nervous system—acquired immunodeficiency syndrome	8.11e-05	0.0105	CbGeAlD
Amprenavir—CYP2D6—nervous system—acquired immunodeficiency syndrome	7.98e-05	0.0103	CbGeAlD
Amprenavir—CYP3A4—central nervous system—acquired immunodeficiency syndrome	7.81e-05	0.0101	CbGeAlD
Amprenavir—CYP2D6—central nervous system—acquired immunodeficiency syndrome	7.68e-05	0.00995	CbGeAlD
Amprenavir—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	7.51e-05	0.00973	CbGeAlD
Amprenavir—ABCB1—digestive system—acquired immunodeficiency syndrome	7.42e-05	0.00961	CbGeAlD
Amprenavir—ABCB1—blood—acquired immunodeficiency syndrome	7.07e-05	0.00915	CbGeAlD
Amprenavir—Hepatobiliary disease—Saquinavir—acquired immunodeficiency syndrome	7.01e-05	0.000564	CcSEcCtD
Amprenavir—Skin disorder—Abacavir—acquired immunodeficiency syndrome	6.96e-05	0.00056	CcSEcCtD
Amprenavir—Anorexia—Nelfinavir—acquired immunodeficiency syndrome	6.95e-05	0.000559	CcSEcCtD
Amprenavir—Anorexia—Stavudine—acquired immunodeficiency syndrome	6.93e-05	0.000557	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Nevirapine—acquired immunodeficiency syndrome	6.86e-05	0.000552	CcSEcCtD
Amprenavir—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	6.85e-05	0.000551	CcSEcCtD
Amprenavir—ABCB1—bone marrow—acquired immunodeficiency syndrome	6.84e-05	0.00886	CbGeAlD
Amprenavir—Anorexia—Abacavir—acquired immunodeficiency syndrome	6.83e-05	0.000549	CcSEcCtD
Amprenavir—ABCB1—spinal cord—acquired immunodeficiency syndrome	6.81e-05	0.00882	CbGeAlD
Amprenavir—Malnutrition—Efavirenz—acquired immunodeficiency syndrome	6.81e-05	0.000547	CcSEcCtD
Amprenavir—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	6.8e-05	0.000547	CcSEcCtD
Amprenavir—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	6.76e-05	0.000544	CcSEcCtD
Amprenavir—Tremor—Indinavir—acquired immunodeficiency syndrome	6.75e-05	0.000543	CcSEcCtD
Amprenavir—Flatulence—Efavirenz—acquired immunodeficiency syndrome	6.71e-05	0.000539	CcSEcCtD
Amprenavir—Hepatobiliary disease—Lamivudine—acquired immunodeficiency syndrome	6.69e-05	0.000538	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Nelfinavir—acquired immunodeficiency syndrome	6.65e-05	0.000534	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Stavudine—acquired immunodeficiency syndrome	6.63e-05	0.000533	CcSEcCtD
Amprenavir—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	6.62e-05	0.000532	CcSEcCtD
Amprenavir—Myalgia—Zidovudine—acquired immunodeficiency syndrome	6.59e-05	0.00053	CcSEcCtD
Amprenavir—Angioedema—Indinavir—acquired immunodeficiency syndrome	6.58e-05	0.000529	CcSEcCtD
Amprenavir—ABCB1—vagina—acquired immunodeficiency syndrome	6.55e-05	0.00849	CbGeAlD
Amprenavir—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	6.55e-05	0.000527	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	6.55e-05	0.000527	CcSEcCtD
Amprenavir—Decreased appetite—Nevirapine—acquired immunodeficiency syndrome	6.55e-05	0.000526	CcSEcCtD
Amprenavir—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	6.54e-05	0.000526	CcSEcCtD
Amprenavir—Erythema multiforme—Ritonavir—acquired immunodeficiency syndrome	6.54e-05	0.000526	CcSEcCtD
Amprenavir—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	6.53e-05	0.000525	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Abacavir—acquired immunodeficiency syndrome	6.53e-05	0.000525	CcSEcCtD
Amprenavir—Discomfort—Zidovudine—acquired immunodeficiency syndrome	6.51e-05	0.000524	CcSEcCtD
Amprenavir—Malnutrition—Delavirdine—acquired immunodeficiency syndrome	6.51e-05	0.000524	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	6.5e-05	0.000523	CcSEcCtD
Amprenavir—Fatigue—Nevirapine—acquired immunodeficiency syndrome	6.49e-05	0.000522	CcSEcCtD
Amprenavir—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	6.43e-05	0.000517	CcSEcCtD
Amprenavir—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	6.42e-05	0.000516	CcSEcCtD
Amprenavir—Flatulence—Delavirdine—acquired immunodeficiency syndrome	6.42e-05	0.000516	CcSEcCtD
Amprenavir—Tremor—Efavirenz—acquired immunodeficiency syndrome	6.38e-05	0.000513	CcSEcCtD
Amprenavir—Decreased appetite—Nelfinavir—acquired immunodeficiency syndrome	6.34e-05	0.00051	CcSEcCtD
Amprenavir—Decreased appetite—Stavudine—acquired immunodeficiency syndrome	6.32e-05	0.000508	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	6.3e-05	0.000506	CcSEcCtD
Amprenavir—Erythema multiforme—Saquinavir—acquired immunodeficiency syndrome	6.29e-05	0.000506	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	6.28e-05	0.000505	CcSEcCtD
Amprenavir—Fatigue—Stavudine—acquired immunodeficiency syndrome	6.27e-05	0.000504	CcSEcCtD
Amprenavir—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	6.24e-05	0.000502	CcSEcCtD
Amprenavir—Decreased appetite—Abacavir—acquired immunodeficiency syndrome	6.23e-05	0.000501	CcSEcCtD
Amprenavir—Angioedema—Efavirenz—acquired immunodeficiency syndrome	6.22e-05	0.0005	CcSEcCtD
Amprenavir—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	6.2e-05	0.000498	CcSEcCtD
Amprenavir—ABCB1—lung—acquired immunodeficiency syndrome	6.2e-05	0.00802	CbGeAlD
Amprenavir—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	6.19e-05	0.000497	CcSEcCtD
Amprenavir—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	6.18e-05	0.000497	CcSEcCtD
Amprenavir—Fatigue—Abacavir—acquired immunodeficiency syndrome	6.18e-05	0.000497	CcSEcCtD
Amprenavir—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	6.16e-05	0.000495	CcSEcCtD
Amprenavir—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	6.14e-05	0.000494	CcSEcCtD
Amprenavir—Myalgia—Indinavir—acquired immunodeficiency syndrome	6.13e-05	0.000493	CcSEcCtD
Amprenavir—Tremor—Delavirdine—acquired immunodeficiency syndrome	6.1e-05	0.000491	CcSEcCtD
Amprenavir—CYP2D6—brain—acquired immunodeficiency syndrome	6.1e-05	0.0079	CbGeAlD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	6.09e-05	0.00049	CcSEcCtD
Amprenavir—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	6.06e-05	0.000487	CcSEcCtD
Amprenavir—Discomfort—Indinavir—acquired immunodeficiency syndrome	6.06e-05	0.000487	CcSEcCtD
Amprenavir—Anorexia—Zidovudine—acquired immunodeficiency syndrome	6.03e-05	0.000484	CcSEcCtD
Amprenavir—Malnutrition—Ritonavir—acquired immunodeficiency syndrome	6.02e-05	0.000484	CcSEcCtD
Amprenavir—Asthenia—Didanosine—acquired immunodeficiency syndrome	6.01e-05	0.000483	CcSEcCtD
Amprenavir—Erythema multiforme—Lamivudine—acquired immunodeficiency syndrome	6.01e-05	0.000483	CcSEcCtD
Amprenavir—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	5.97e-05	0.00048	CcSEcCtD
Amprenavir—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	5.95e-05	0.000479	CcSEcCtD
Amprenavir—Angioedema—Delavirdine—acquired immunodeficiency syndrome	5.95e-05	0.000478	CcSEcCtD
Amprenavir—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	5.95e-05	0.000478	CcSEcCtD
Amprenavir—Flatulence—Ritonavir—acquired immunodeficiency syndrome	5.93e-05	0.000477	CcSEcCtD
Amprenavir—Pruritus—Didanosine—acquired immunodeficiency syndrome	5.93e-05	0.000477	CcSEcCtD
Amprenavir—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	5.86e-05	0.000471	CcSEcCtD
Amprenavir—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	5.83e-05	0.000469	CcSEcCtD
Amprenavir—Malnutrition—Saquinavir—acquired immunodeficiency syndrome	5.8e-05	0.000466	CcSEcCtD
Amprenavir—Myalgia—Efavirenz—acquired immunodeficiency syndrome	5.79e-05	0.000466	CcSEcCtD
Amprenavir—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	5.77e-05	0.000464	CcSEcCtD
Amprenavir—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	5.76e-05	0.000464	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	5.76e-05	0.000463	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	5.75e-05	0.000463	CcSEcCtD
Amprenavir—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	5.75e-05	0.000462	CcSEcCtD
Amprenavir—ABCB1—nervous system—acquired immunodeficiency syndrome	5.74e-05	0.00743	CbGeAlD
Amprenavir—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	5.73e-05	0.000461	CcSEcCtD
Amprenavir—Discomfort—Efavirenz—acquired immunodeficiency syndrome	5.72e-05	0.00046	CcSEcCtD
Amprenavir—Flatulence—Saquinavir—acquired immunodeficiency syndrome	5.71e-05	0.000459	CcSEcCtD
Amprenavir—Skin disorder—Indinavir—acquired immunodeficiency syndrome	5.71e-05	0.000459	CcSEcCtD
Amprenavir—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	5.68e-05	0.000456	CcSEcCtD
Amprenavir—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	5.66e-05	0.000455	CcSEcCtD
Amprenavir—Tremor—Ritonavir—acquired immunodeficiency syndrome	5.64e-05	0.000454	CcSEcCtD
Amprenavir—Anorexia—Indinavir—acquired immunodeficiency syndrome	5.6e-05	0.000451	CcSEcCtD
Amprenavir—Myalgia—Delavirdine—acquired immunodeficiency syndrome	5.54e-05	0.000446	CcSEcCtD
Amprenavir—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	5.53e-05	0.000445	CcSEcCtD
Amprenavir—ABCB1—central nervous system—acquired immunodeficiency syndrome	5.53e-05	0.00715	CbGeAlD
Amprenavir—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	5.49e-05	0.000442	CcSEcCtD
Amprenavir—Discomfort—Delavirdine—acquired immunodeficiency syndrome	5.48e-05	0.00044	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	5.46e-05	0.000439	CcSEcCtD
Amprenavir—Fatigue—Zidovudine—acquired immunodeficiency syndrome	5.45e-05	0.000438	CcSEcCtD
Amprenavir—Flatulence—Lamivudine—acquired immunodeficiency syndrome	5.45e-05	0.000438	CcSEcCtD
Amprenavir—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	5.45e-05	0.000438	CcSEcCtD
Amprenavir—Tremor—Saquinavir—acquired immunodeficiency syndrome	5.43e-05	0.000437	CcSEcCtD
Amprenavir—Asthenia—Nevirapine—acquired immunodeficiency syndrome	5.4e-05	0.000435	CcSEcCtD
Amprenavir—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	5.39e-05	0.000434	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	5.36e-05	0.000431	CcSEcCtD
Amprenavir—Pruritus—Nevirapine—acquired immunodeficiency syndrome	5.33e-05	0.000428	CcSEcCtD
Amprenavir—Vomiting—Didanosine—acquired immunodeficiency syndrome	5.33e-05	0.000428	CcSEcCtD
Amprenavir—Anorexia—Efavirenz—acquired immunodeficiency syndrome	5.29e-05	0.000426	CcSEcCtD
Amprenavir—Rash—Didanosine—acquired immunodeficiency syndrome	5.28e-05	0.000425	CcSEcCtD
Amprenavir—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	5.28e-05	0.000424	CcSEcCtD
Amprenavir—Dermatitis—Didanosine—acquired immunodeficiency syndrome	5.28e-05	0.000424	CcSEcCtD
Amprenavir—Headache—Didanosine—acquired immunodeficiency syndrome	5.25e-05	0.000422	CcSEcCtD
Amprenavir—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	5.23e-05	0.000421	CcSEcCtD
Amprenavir—Asthenia—Stavudine—acquired immunodeficiency syndrome	5.22e-05	0.00042	CcSEcCtD
Amprenavir—Tremor—Lamivudine—acquired immunodeficiency syndrome	5.18e-05	0.000417	CcSEcCtD
Amprenavir—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	5.17e-05	0.000416	CcSEcCtD
Amprenavir—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	5.16e-05	0.000415	CcSEcCtD
Amprenavir—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	5.16e-05	0.000415	CcSEcCtD
Amprenavir—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	5.15e-05	0.000414	CcSEcCtD
Amprenavir—Pruritus—Stavudine—acquired immunodeficiency syndrome	5.15e-05	0.000414	CcSEcCtD
Amprenavir—Asthenia—Abacavir—acquired immunodeficiency syndrome	5.14e-05	0.000413	CcSEcCtD
Amprenavir—Myalgia—Ritonavir—acquired immunodeficiency syndrome	5.13e-05	0.000412	CcSEcCtD
Amprenavir—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	5.11e-05	0.000411	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	5.09e-05	0.000409	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	5.08e-05	0.000408	CcSEcCtD
Amprenavir—Pruritus—Abacavir—acquired immunodeficiency syndrome	5.07e-05	0.000408	CcSEcCtD
Amprenavir—Fatigue—Indinavir—acquired immunodeficiency syndrome	5.07e-05	0.000408	CcSEcCtD
Amprenavir—Anorexia—Delavirdine—acquired immunodeficiency syndrome	5.07e-05	0.000407	CcSEcCtD
Amprenavir—Discomfort—Ritonavir—acquired immunodeficiency syndrome	5.06e-05	0.000407	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	5.06e-05	0.000407	CcSEcCtD
Amprenavir—Angioedema—Lamivudine—acquired immunodeficiency syndrome	5.05e-05	0.000406	CcSEcCtD
Amprenavir—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	5e-05	0.000402	CcSEcCtD
Amprenavir—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	4.99e-05	0.000401	CcSEcCtD
Amprenavir—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	4.99e-05	0.000401	CcSEcCtD
Amprenavir—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	4.98e-05	0.0004	CcSEcCtD
Amprenavir—Nausea—Didanosine—acquired immunodeficiency syndrome	4.98e-05	0.0004	CcSEcCtD
Amprenavir—Myalgia—Saquinavir—acquired immunodeficiency syndrome	4.93e-05	0.000397	CcSEcCtD
Amprenavir—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	4.9e-05	0.000394	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	4.9e-05	0.000394	CcSEcCtD
Amprenavir—Discomfort—Saquinavir—acquired immunodeficiency syndrome	4.87e-05	0.000392	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	4.84e-05	0.000389	CcSEcCtD
Amprenavir—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	4.83e-05	0.000388	CcSEcCtD
Amprenavir—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	4.82e-05	0.000388	CcSEcCtD
Amprenavir—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	4.81e-05	0.000387	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	4.8e-05	0.000386	CcSEcCtD
Amprenavir—Vomiting—Nevirapine—acquired immunodeficiency syndrome	4.79e-05	0.000385	CcSEcCtD
Amprenavir—Fatigue—Efavirenz—acquired immunodeficiency syndrome	4.79e-05	0.000385	CcSEcCtD
Amprenavir—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	4.77e-05	0.000384	CcSEcCtD
Amprenavir—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	4.77e-05	0.000384	CcSEcCtD
Amprenavir—Rash—Nevirapine—acquired immunodeficiency syndrome	4.75e-05	0.000382	CcSEcCtD
Amprenavir—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	4.74e-05	0.000382	CcSEcCtD
Amprenavir—Headache—Nevirapine—acquired immunodeficiency syndrome	4.72e-05	0.000379	CcSEcCtD
Amprenavir—Myalgia—Lamivudine—acquired immunodeficiency syndrome	4.71e-05	0.000378	CcSEcCtD
Amprenavir—Anorexia—Ritonavir—acquired immunodeficiency syndrome	4.68e-05	0.000377	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	4.67e-05	0.000376	CcSEcCtD
Amprenavir—Discomfort—Lamivudine—acquired immunodeficiency syndrome	4.65e-05	0.000374	CcSEcCtD
Amprenavir—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	4.65e-05	0.000374	CcSEcCtD
Amprenavir—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	4.64e-05	0.000373	CcSEcCtD
Amprenavir—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	4.64e-05	0.000373	CcSEcCtD
Amprenavir—Vomiting—Stavudine—acquired immunodeficiency syndrome	4.62e-05	0.000372	CcSEcCtD
Amprenavir—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	4.62e-05	0.000371	CcSEcCtD
Amprenavir—Rash—Nelfinavir—acquired immunodeficiency syndrome	4.6e-05	0.00037	CcSEcCtD
Amprenavir—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	4.6e-05	0.000369	CcSEcCtD
Amprenavir—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	4.59e-05	0.000369	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	4.59e-05	0.000369	CcSEcCtD
Amprenavir—Rash—Stavudine—acquired immunodeficiency syndrome	4.59e-05	0.000369	CcSEcCtD
Amprenavir—Fatigue—Delavirdine—acquired immunodeficiency syndrome	4.58e-05	0.000368	CcSEcCtD
Amprenavir—Dermatitis—Stavudine—acquired immunodeficiency syndrome	4.58e-05	0.000368	CcSEcCtD
Amprenavir—Headache—Nelfinavir—acquired immunodeficiency syndrome	4.57e-05	0.000367	CcSEcCtD
Amprenavir—Headache—Stavudine—acquired immunodeficiency syndrome	4.56e-05	0.000366	CcSEcCtD
Amprenavir—Vomiting—Abacavir—acquired immunodeficiency syndrome	4.56e-05	0.000366	CcSEcCtD
Amprenavir—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	4.54e-05	0.000365	CcSEcCtD
Amprenavir—Asthenia—Zidovudine—acquired immunodeficiency syndrome	4.54e-05	0.000365	CcSEcCtD
Amprenavir—Rash—Abacavir—acquired immunodeficiency syndrome	4.52e-05	0.000363	CcSEcCtD
Amprenavir—Dermatitis—Abacavir—acquired immunodeficiency syndrome	4.51e-05	0.000363	CcSEcCtD
Amprenavir—Anorexia—Saquinavir—acquired immunodeficiency syndrome	4.51e-05	0.000363	CcSEcCtD
Amprenavir—Headache—Abacavir—acquired immunodeficiency syndrome	4.49e-05	0.000361	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	4.48e-05	0.00036	CcSEcCtD
Amprenavir—Nausea—Nevirapine—acquired immunodeficiency syndrome	4.47e-05	0.00036	CcSEcCtD
Amprenavir—Pruritus—Zidovudine—acquired immunodeficiency syndrome	4.47e-05	0.00036	CcSEcCtD
Amprenavir—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	4.43e-05	0.000356	CcSEcCtD
Amprenavir—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	4.41e-05	0.000355	CcSEcCtD
Amprenavir—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	4.39e-05	0.000353	CcSEcCtD
Amprenavir—ABCB1—brain—acquired immunodeficiency syndrome	4.39e-05	0.00568	CbGeAlD
Amprenavir—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	4.38e-05	0.000352	CcSEcCtD
Amprenavir—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	4.35e-05	0.000349	CcSEcCtD
Amprenavir—Nausea—Nelfinavir—acquired immunodeficiency syndrome	4.33e-05	0.000348	CcSEcCtD
Amprenavir—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	4.32e-05	0.000348	CcSEcCtD
Amprenavir—Nausea—Stavudine—acquired immunodeficiency syndrome	4.32e-05	0.000347	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	4.31e-05	0.000347	CcSEcCtD
Amprenavir—Anorexia—Lamivudine—acquired immunodeficiency syndrome	4.3e-05	0.000346	CcSEcCtD
Amprenavir—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	4.27e-05	0.000343	CcSEcCtD
Amprenavir—Nausea—Abacavir—acquired immunodeficiency syndrome	4.26e-05	0.000342	CcSEcCtD
Amprenavir—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	4.25e-05	0.000342	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	4.24e-05	0.000341	CcSEcCtD
Amprenavir—ABCB1—lymph node—acquired immunodeficiency syndrome	4.24e-05	0.00549	CbGeAlD
Amprenavir—Fatigue—Ritonavir—acquired immunodeficiency syndrome	4.24e-05	0.000341	CcSEcCtD
Amprenavir—Asthenia—Indinavir—acquired immunodeficiency syndrome	4.22e-05	0.000339	CcSEcCtD
Amprenavir—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	4.2e-05	0.000338	CcSEcCtD
Amprenavir—Pruritus—Indinavir—acquired immunodeficiency syndrome	4.16e-05	0.000334	CcSEcCtD
Amprenavir—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	4.11e-05	0.000331	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	4.11e-05	0.000331	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	4.08e-05	0.000328	CcSEcCtD
Amprenavir—Fatigue—Saquinavir—acquired immunodeficiency syndrome	4.08e-05	0.000328	CcSEcCtD
Amprenavir—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	4.05e-05	0.000326	CcSEcCtD
Amprenavir—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	4.02e-05	0.000323	CcSEcCtD
Amprenavir—Vomiting—Zidovudine—acquired immunodeficiency syndrome	4.02e-05	0.000323	CcSEcCtD
Amprenavir—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	4.02e-05	0.000323	CcSEcCtD
Amprenavir—Rash—Zidovudine—acquired immunodeficiency syndrome	3.99e-05	0.00032	CcSEcCtD
Amprenavir—Asthenia—Efavirenz—acquired immunodeficiency syndrome	3.98e-05	0.00032	CcSEcCtD
Amprenavir—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	3.98e-05	0.00032	CcSEcCtD
Amprenavir—Headache—Zidovudine—acquired immunodeficiency syndrome	3.96e-05	0.000318	CcSEcCtD
Amprenavir—Pruritus—Efavirenz—acquired immunodeficiency syndrome	3.93e-05	0.000316	CcSEcCtD
Amprenavir—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	3.92e-05	0.000315	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	3.9e-05	0.000313	CcSEcCtD
Amprenavir—Fatigue—Lamivudine—acquired immunodeficiency syndrome	3.89e-05	0.000313	CcSEcCtD
Amprenavir—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	3.88e-05	0.000312	CcSEcCtD
Amprenavir—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	3.87e-05	0.000311	CcSEcCtD
Amprenavir—Asthenia—Delavirdine—acquired immunodeficiency syndrome	3.81e-05	0.000307	CcSEcCtD
Amprenavir—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	3.8e-05	0.000306	CcSEcCtD
Amprenavir—Pruritus—Delavirdine—acquired immunodeficiency syndrome	3.76e-05	0.000302	CcSEcCtD
Amprenavir—Nausea—Zidovudine—acquired immunodeficiency syndrome	3.75e-05	0.000302	CcSEcCtD
Amprenavir—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	3.74e-05	0.000301	CcSEcCtD
Amprenavir—Vomiting—Indinavir—acquired immunodeficiency syndrome	3.74e-05	0.000301	CcSEcCtD
Amprenavir—Rash—Indinavir—acquired immunodeficiency syndrome	3.71e-05	0.000298	CcSEcCtD
Amprenavir—Dermatitis—Indinavir—acquired immunodeficiency syndrome	3.7e-05	0.000298	CcSEcCtD
Amprenavir—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	3.69e-05	0.000297	CcSEcCtD
Amprenavir—Headache—Indinavir—acquired immunodeficiency syndrome	3.68e-05	0.000296	CcSEcCtD
Amprenavir—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	3.64e-05	0.000292	CcSEcCtD
Amprenavir—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	3.57e-05	0.000287	CcSEcCtD
Amprenavir—Vomiting—Efavirenz—acquired immunodeficiency syndrome	3.53e-05	0.000284	CcSEcCtD
Amprenavir—Asthenia—Ritonavir—acquired immunodeficiency syndrome	3.53e-05	0.000284	CcSEcCtD
Amprenavir—Rash—Efavirenz—acquired immunodeficiency syndrome	3.5e-05	0.000282	CcSEcCtD
Amprenavir—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	3.5e-05	0.000281	CcSEcCtD
Amprenavir—Nausea—Indinavir—acquired immunodeficiency syndrome	3.49e-05	0.000281	CcSEcCtD
Amprenavir—Headache—Efavirenz—acquired immunodeficiency syndrome	3.48e-05	0.00028	CcSEcCtD
Amprenavir—Pruritus—Ritonavir—acquired immunodeficiency syndrome	3.48e-05	0.00028	CcSEcCtD
Amprenavir—Asthenia—Saquinavir—acquired immunodeficiency syndrome	3.39e-05	0.000273	CcSEcCtD
Amprenavir—Vomiting—Delavirdine—acquired immunodeficiency syndrome	3.38e-05	0.000272	CcSEcCtD
Amprenavir—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	3.36e-05	0.00027	CcSEcCtD
Amprenavir—Rash—Delavirdine—acquired immunodeficiency syndrome	3.35e-05	0.000269	CcSEcCtD
Amprenavir—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	3.35e-05	0.000269	CcSEcCtD
Amprenavir—Pruritus—Saquinavir—acquired immunodeficiency syndrome	3.35e-05	0.000269	CcSEcCtD
Amprenavir—Headache—Delavirdine—acquired immunodeficiency syndrome	3.33e-05	0.000268	CcSEcCtD
Amprenavir—Nausea—Efavirenz—acquired immunodeficiency syndrome	3.3e-05	0.000265	CcSEcCtD
Amprenavir—Asthenia—Lamivudine—acquired immunodeficiency syndrome	3.24e-05	0.00026	CcSEcCtD
Amprenavir—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	3.24e-05	0.00026	CcSEcCtD
Amprenavir—Pruritus—Lamivudine—acquired immunodeficiency syndrome	3.19e-05	0.000257	CcSEcCtD
Amprenavir—Nausea—Delavirdine—acquired immunodeficiency syndrome	3.16e-05	0.000254	CcSEcCtD
Amprenavir—Vomiting—Ritonavir—acquired immunodeficiency syndrome	3.12e-05	0.000251	CcSEcCtD
Amprenavir—Rash—Ritonavir—acquired immunodeficiency syndrome	3.1e-05	0.000249	CcSEcCtD
Amprenavir—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	3.1e-05	0.000249	CcSEcCtD
Amprenavir—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	3.09e-05	0.000248	CcSEcCtD
Amprenavir—Headache—Ritonavir—acquired immunodeficiency syndrome	3.08e-05	0.000248	CcSEcCtD
Amprenavir—Vomiting—Saquinavir—acquired immunodeficiency syndrome	3.01e-05	0.000242	CcSEcCtD
Amprenavir—Rash—Saquinavir—acquired immunodeficiency syndrome	2.98e-05	0.00024	CcSEcCtD
Amprenavir—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	2.98e-05	0.00024	CcSEcCtD
Amprenavir—Headache—Saquinavir—acquired immunodeficiency syndrome	2.96e-05	0.000238	CcSEcCtD
Amprenavir—Nausea—Ritonavir—acquired immunodeficiency syndrome	2.92e-05	0.000235	CcSEcCtD
Amprenavir—Vomiting—Lamivudine—acquired immunodeficiency syndrome	2.87e-05	0.000231	CcSEcCtD
Amprenavir—Rash—Lamivudine—acquired immunodeficiency syndrome	2.85e-05	0.000229	CcSEcCtD
Amprenavir—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	2.84e-05	0.000229	CcSEcCtD
Amprenavir—Headache—Lamivudine—acquired immunodeficiency syndrome	2.83e-05	0.000227	CcSEcCtD
Amprenavir—Nausea—Saquinavir—acquired immunodeficiency syndrome	2.81e-05	0.000226	CcSEcCtD
Amprenavir—Nausea—Lamivudine—acquired immunodeficiency syndrome	2.68e-05	0.000216	CcSEcCtD
